
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
GLP1R and GIPR are receptors for GLP‑1 and GIP, key incretin regulators of postprandial metabolism. Activation of GLP1R and GIPR elevates intracellular cAMP concentration. GLP1R/GIPR dual agonists deliver combined benefits for glycemic control and weight loss, as represented by Tirzepatide. Our GLP1R GIPR dual reporter stable cell lines are validated for cAMP reporter assays to support your drug discovery programs.